A young hispanic with c.1646G>A mutation exhibits severe cystic fibrosis lung disease: Is ivacaftor an option for therapy?

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 7, 2012, Pages 694-696

  Yarlagadda, Sunitha ^a   Zhang, Weiqiang ^a   Penmatsa, Himabindu ^a   Ren, Aixia ^a   Arora, Kavisha ^a   Naren, Anjaparavanda P ^a   Khan, Fatima Anmol I ^a,b   Donnellan, Catherine A ^a   Srinivasan, Saumini ^a   Stokes, Dennis C ^a   Kappes, John C ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b CHRISTIAN BROTHERS UNIVERSITY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR; VITAMIN;

BACTERIAL STRAIN; BACTERIUM ISOLATE; BRONCHIECTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYSTIC FIBROSIS; DEHYDRATION; DISEASE EXACERBATION; ENDOPLASMIC RETICULUM; ETHNIC GROUP; FAILURE TO THRIVE; GENE MUTATION; GROWTH RETARDATION; HETEROZYGOTE; HISPANIC; HOSPITALIZATION; HUMAN; HUMAN CELL; HYPERCHLOREMIA; HYPOKALEMIA; LETTER; LUNG DISEASE; LUNG FUNCTION TEST; MALNUTRITION; METABOLIC ALKALOSIS; PERTUSSIS; PRIORITY JOURNAL; PROBABILITY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SINUSITIS; THORAX RADIOGRAPHY; THYROID CELL; VOMITING;

EID: 84867134519     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.186.7.694     Document Type: Letter

References (12)

1. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990;63:827-834. (Pubitemid 120035055)
2. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-1254. (Pubitemid 23201140)
3. Penmatsa H, Frederick CA, Nekkalapu S, Conoley VG, Zhang W, Li C, Kappes J, Stokes DC, Naren AP. Clinical and molecular characterization of S1118F-CFTR. Pediatr Pulmonol 2009;44:1003-1009.
4. Rohlfs EM, Zhou Z, Heim RA, Nagan N, Rosenblum LS, Flynn K, Scholl T, Akmaev VR, Sirko-Osadsa DA, Allitto BA, et al. Cystic fibrosis carrier testing in an ethnically diverse US population. Clin Chem 2011;57:841-848.
5. Sugarman EA, Rohlfs EM, Silverman LM, Allitto BA. CFTR mutation distribution among Hispanic US and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations. Genet Med 2004;6:392-399. (Pubitemid 39304376)
6. Curtis A, Richardson RJ, Boohene J, Jackson A, Nelson R, Bhattacharya SS. Absence of cystic fibrosis mutations in a large Asian population sample and occurrence of a homozygous S549N mutation in an inbred Pakistani family. J Med Genet 1993;30:164-166. (Pubitemid 23078398)
7. Van Goor F, Hadida S, Grootenhuis PD, Burton B, Cao D, Neuberger T, Turnbull A, Singh A, Joubran J, Hazlewood A, et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci U S A 2009;106:18825-18830.
8. Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Dřevínek P, Griese M, McKone EF, Wainwright CE, Konstan MW, et al.; VX08-770-102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011;365:1663-1672.
9. Yu H, Burton B, Huang CJ, Worley J, Cao D, Johnson JP Jr, Urrutia A, Joubran J, Seepersaud S, Sussky K, et al. Ivacaftor potentiation of multiple CFTR channels with gating mutations. J Cyst Fibros 2012;11:237-245.
10. Cystic Fibrosis Foundation. FDA Approves Kalydeco (VX-770) - first drug that targets the underlying cause of cystic fibrosis [accessed 2012 January 31]. Available from: http://www.cff.org/aboutCFFoundation/NewsEvents/1-31-FDA- Approves-Kalydeco.cfm
11. Van Goor F, Hadida S, Grootenhuis PD, Burton B, Stack JH, Straley KS, Decker CJ, Miller M, McCartney J, Olson ER, et al. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci U S A 2011;108:18843-18848.
12. Li C, Krishnamurthy PC, Penmatsa H, Marrs KL, Wang XQ, Zaccolo M, Jalink K, Li M, Nelson DJ, Schuetz JD, Naren AP. Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia. Cell 2007;13:940-951. (Pubitemid 350138082)